GeneFerm Biotechnology Co Ltd
GeneFerm Biotechnology Co., Ltd. develops, manufactures, and sells fermented health products in Taiwan and internationally. The company offers microbial fermentation products, including fungi, bacteria, lactic acid bacteria, yeast, algae, etc.; bio fermented ingredients, such as nattomena, natto fermented powder, red yeast rice fermented powder, antrodia cinnamomea mycelia powder, cordyceps, reis… Read more
GeneFerm Biotechnology Co Ltd (1796) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2025: 0.002x
Based on the latest financial reports, GeneFerm Biotechnology Co Ltd (1796) has a cash flow conversion efficiency ratio of 0.002x as of June 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$1.45 Million) by net assets (NT$794.03 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
GeneFerm Biotechnology Co Ltd - Cash Flow Conversion Efficiency Trend (2017–2024)
This chart illustrates how GeneFerm Biotechnology Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
GeneFerm Biotechnology Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of GeneFerm Biotechnology Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
LeadDesk Oyj
HE:LEADD
|
0.193x |
|
Sempio Foods
KO:007540
|
0.056x |
|
Bwe Drilling Ltd
AU:BWE
|
N/A |
|
Dynamic Group Holdings Ltd
AU:DDB
|
0.331x |
|
Lacroix Group SA
PA:LACR
|
0.145x |
|
Dusk Group Limited
F:6EA
|
N/A |
|
446540
KQ:446540
|
0.032x |
|
Youngbo Chem
KO:014440
|
0.027x |
Annual Cash Flow Conversion Efficiency for GeneFerm Biotechnology Co Ltd (2017–2024)
The table below shows the annual cash flow conversion efficiency of GeneFerm Biotechnology Co Ltd from 2017 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | NT$788.18 Million | NT$8.09 Million | 0.010x | -95.18% |
| 2023-12-31 | NT$892.84 Million | NT$190.31 Million | 0.213x | +44.64% |
| 2022-12-31 | NT$830.77 Million | NT$122.43 Million | 0.147x | -1.82% |
| 2021-12-31 | NT$747.66 Million | NT$112.23 Million | 0.150x | +5.41% |
| 2020-12-31 | NT$396.19 Million | NT$56.42 Million | 0.142x | +825.46% |
| 2019-12-31 | NT$954.50 Million | NT$14.69 Million | 0.015x | -84.79% |
| 2018-12-31 | NT$416.51 Million | NT$42.14 Million | 0.101x | -47.83% |
| 2017-12-31 | NT$314.95 Million | NT$61.08 Million | 0.194x | -- |